Bogda Koczwara, Director of Australian Research Centre for Cancer Survivorship, shared a post on LinkedIn:
“Exercise, stopping smoking, weight control and blood-pressure management aren’t generic lifestyle advice – they extend both cancer survival and heart health.
Thank you Jason Gale for clearly articulating the challenge and the opportunity – oncologists can and should play an important role in mitigating the risk of cardiovascular disease after cancer!”
Jason Gale, Bloomberg senior editor and Biosecurity correspondent at Bloomberg News, shared Bogda Koczwara‘s post, adding:
“Cancer survival is one of modern medicine’s great success stories, but it’s coming with a catch.
I reported this piece after speaking with Bogda Koczwara, Javid Moslehi and Susan Cheng – seeing a growing, underrecognized problem: cancer drugs that save lives can quietly damage the heart, sometimes long after patients are declared ‘cured’.
From chemotherapy used since the 1960s to today’s immune and targeted therapies, treatment has become a cardiovascular risk factor in its own right. Survivors are living long enough for that risk to surface – often outside oncology clinics and beyond routine follow-up.
This story looks at how medicine is trying to catch up, why cardiooncology clinics are expanding, and where the system still falls short for cancer survivors.”
More posts featuring Bogda Koczwara on OncoDaily.